Moderna flu vaccine shows promising phase three trial results
Moderna compared the flu vaccine, dubbed mRNA-1010, to a currently approved seasonal flu vaccine from GlaxoSmithKline called Fluarix.
Source: cnbc.com
Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna compared the flu vaccine, dubbed mRNA-1010, to a currently approved seasonal flu vaccine from GlaxoSmithKline called Fluarix.
Moderna expects to launch up to 15 new products over the next five years 'addressing high unmet needs.'
As COVID vaccine sales fall, Moderna releases positive results from mRNA flu vaccine, adds new development programs
It’s that time of year again as COVID-19, the flu and RSV are beginning to circulate at the same time.
The booster will be available starting later this week.